The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EACH: A randomised phase II study evaluating the safety and anti-tumour activity of the combination of avelumab and cetuximab relative to avelumab monotherapy in recurrent/metastatic head and neck squamous cell cancer.
 
Martin David Forster
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Novartis; PharmaMar; Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; Merck; MSD
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Roche
 
Joseph J. Sacco
Honoraria - Amgen; Bristol-Myers Squibb; Immunocore; MSD
Consulting or Advisory Role - Delcath Systems; Immunocore; MSD
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); MSD (Inst); Replimune (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Anthony Hee Kong
Honoraria - Merck; MSD
Consulting or Advisory Role - Amgen; Avvinity; Merck; MSD; Puma Biotechnology
Speakers' Bureau - Merck; MSD
Research Funding - AstraZeneca; Puma Biotechnology
 
Graham Wheeler
Honoraria - Novametrics Consulting
 
Sharon Forsyth
Research Funding - Biocompatibles (Inst)
 
Reshma Bhat
No Relationships to Disclose
 
Kameka Blair
No Relationships to Disclose
 
Helen Lowe
No Relationships to Disclose
 
Victoria J Spanswick
No Relationships to Disclose
 
Leah Ensell
No Relationships to Disclose
 
John A. Hartley
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - ADC Therapeutics
Research Funding - ADC Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - ADC Therapeutics
 
Laura White
No Relationships to Disclose